Compare PYPL & KMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PYPL | KMB |
|---|---|---|
| Founded | 1998 | 1910 |
| Country | United States | United States |
| Employees | N/A | 36000 |
| Industry | Business Services | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1B | 33.2B |
| IPO Year | 2015 | 1994 |
| Metric | PYPL | KMB |
|---|---|---|
| Price | $44.41 | $97.88 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 31 | 12 |
| Target Price | $64.04 | ★ $124.83 |
| AVG Volume (30 Days) | ★ 22.0M | 4.4M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | 1.23% | ★ 5.12% |
| EPS Growth | ★ 35.59 | N/A |
| EPS | 5.41 | ★ 6.07 |
| Revenue | ★ $33,172,000,000.00 | $16,447,000,000.00 |
| Revenue This Year | $4.83 | $3.90 |
| Revenue Next Year | $4.41 | $3.44 |
| P/E Ratio | ★ $8.43 | $16.48 |
| Revenue Growth | ★ 4.32 | N/A |
| 52 Week Low | $38.46 | $96.26 |
| 52 Week High | $79.50 | $147.12 |
| Indicator | PYPL | KMB |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 30.67 |
| Support Level | $38.46 | $97.86 |
| Resistance Level | $48.21 | $102.54 |
| Average True Range (ATR) | 2.05 | 2.18 |
| MACD | 0.43 | -1.36 |
| Stochastic Oscillator | 51.41 | 0.07 |
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 434 million active accounts at the end of 2024. The company also owns Venmo, a person-to-person payment platform.
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.